Brazilian researchers close to biventricular CAD trial milestone
This article was originally published in Clinica
Brazilian researchers are claiming to be close to launching the country's first human trials of an implantable biventricular cardiac assist device (CAD). According to an announcement posted yesterday on the Hospitalar website, citing the Instituto Dante Pazzanese de Cardiologia, in Sao Paulo, the CAD developed in conjunction with the Fundacao Adib Jatene is about to undergo final trials in calves. Human trials can begin, reportedly, once the device demonstrates 30-day survival in at least three animals.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.